Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Disability rights activist and author Alice Wong dies at 51 - 2Aluminum salts emerge as likely target as health officials scrutinize childhood vaccines
- 3Wonderful Sea shores All over the Planet
- 4Turkey key underlying issue as Israel, Greece, Cyprus hold summit
- 5Putin, Netanyahu discuss Middle East in phone call, Kremlin says
- The Best Business visionaries Under 30
- Songbirds swap colorful plumage genes across species lines among their evolutionary neighbors
- Cyber Monday Paramount+ deal: Save 50% and stream these buzzy Taylor Sheridan shows
- Well known SUVs With Low Energy Utilization In 2024
- I traveled to 13 countries in 2025. This small island nation surprised me the most.
- The Most Compelling Innovation Advancements Somewhat recently
- 5 Morning Schedules That Stimulate Your Day
- Truly amazing Palaces: Which Is Your Number one?
- Can scientists detect life without knowing what it looks like? Research using machine learning offers a new way
